10-Q: PreAxia Health Care Payment Systems Faces Severe Going Concern Doubts Amidst Minimal Cash and Mounting Deficits

PreAxia Health Care Payment Systems Inc. filed its Q3 2025 10-Q, revealing a critical financial state with only $3 in cash, substantial accumulated and working capital deficits, and explicit doubt about its ability to continue as a going concern, despite a reduction in net loss.

Summary

• PreAxia Health Care Payment Systems Inc. reported a cash balance of only $3 as of February 28, 2025, a decrease from $14 as of May 31, 2024.
• The company's total assets stood at $3, while total liabilities were $2,427,938 as of February 28, 2025.
• PreAxia reported a stockholders' deficit of $(2,427,935) and an accumulated deficit of $(5,160,136) as of February 28, 2025.
• For the nine months ended February 28, 2025, the company incurred a net loss of $(31,756), a significant improvement from a net loss of $(94,838) for the same period in the prior year.
• The company generated no revenue for the three and nine months ended February 28, 2025, and February 29, 2024.
• Cash provided by operating activities for the nine months ended February 28, 2025, was $387, compared to cash used of $(17,074) in the prior year, primarily due to advances from a related party.
• Management concluded that the company's disclosure controls and procedures were not effective as of February 28, 2025.
• The company explicitly stated that there is substantial doubt about its ability to continue as a going concern.
• PreAxia plans to raise an estimated $1,000,000 over the next twelve months to cover $300,000 for arms-length creditors and $700,000 to complete its business plan, primarily through private placement of equity securities or loans.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to the severe going concern issues, critically low cash balance, substantial deficits, lack of revenue, and ineffective internal controls, despite a reduction in net loss.

Positives

• Net loss for the nine months ended February 28, 2025, significantly decreased to $(31,756) from $(94,838) in the comparable prior period.
• Cash flow from operating activities improved to a positive $387 for the nine months ended February 28, 2025, compared to cash used of $(17,074) in the prior year, largely due to related party advances.

Negatives

• The company has a critically low cash balance of $3 as of February 28, 2025.
• PreAxia reported a substantial working capital deficit of $(2,427,935) and an accumulated deficit of $(5,160,136).
• The company has generated no revenue for the periods presented, indicating a lack of operational income.
• Management concluded that disclosure controls and procedures were not effective, raising concerns about financial reporting reliability.
• There is substantial doubt about the company's ability to continue as a going concern, highlighting severe financial instability.
• The company is heavily reliant on related party financing, with significant amounts owed to its CEO and Director, Tom Zapatinas, totaling over $1.9 million.

Risks

• Substantial doubt about the company's ability to continue as a going concern due to recurring losses and insufficient capital.
• Inability to develop additional sources of capital or achieve profitable operations.
• Potential for undue restrictions on operations if debt financing is obtained.
• Substantial dilution for current stockholders if equity financing is pursued.
• No assurance that additional financing will be available when needed or on commercially reasonable terms.
• Risk of scaling down or ceasing business operations if financing is not obtained timely.
• Fluctuations and difficulty in forecasting operating results.
• Inability to attract and retain qualified personnel.
• Inability to protect technology.
• Competition within the healthcare payment processing market.

Future Outlook

PreAxia plans to raise an estimated $1,000,000 over the next twelve months to fund operations, including $300,000 for arms-length creditors and $700,000 to complete its business plan. The company intends to penetrate healthcare processing markets in Canada, the United States, and worldwide, build strategic alliances, and fill senior management, sales, administrative, and engineering positions. There is no assurance that the company will be able to obtain the required funds or achieve profitable operations.

Management Comments

• "The Company's ability to continue as a going concern is dependent upon its ability to develop additional sources of capital and to ultimately achieve profitable operations."
• "The Company hopes to be able to attract suitable investors for our business plan, which will not require us to use our cash. There can be no assurance that the Company will be successful in this situation."
• "There can be no assurance that additional financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms."

Industry Context

PreAxia operates in the emerging health payment market, specifically targeting opportunities related to the growth of health spending accounts (HSAs). The company notes a rapid shift towards consumer-directed healthcare, creating significant opportunities for financial services and insurance industries. Studies suggest that HSAs in the U.S. reached $123.3 billion in assets and 37.4 million consumers in 2023, an 18% increase in assets over the prior year, indicating a growing market opportunity that PreAxia intends to capitalize on, initially in Canada.

Comparison to Industry Standards

• The document highlights the significant growth in the U.S. HSA market, reaching $123.3 billion in assets and 37.4 million consumers in 2023, an 18% increase over the prior year. This indicates a robust and expanding market that PreAxia aims to enter.
• However, the company's current financial performance, with zero revenue and substantial deficits, stands in stark contrast to the reported market growth, indicating it has not yet captured any meaningful share or generated operational success within this growing industry.
• The filing does not provide specific comparable companies, projects, or financial results from industry peers to benchmark PreAxia's performance directly against established players or successful startups in the healthcare payment processing or HSA administration sectors.

Corporate Governance

Related Party Transactions

• Accounts payable and accrued liabilities due to Tom Zapatinas (CEO and Director) totaled $300,000 as of February 28, 2025.
• Advances payable due to Tom Zapatinas totaled $101,182 as of February 28, 2025; these advances are non-interest bearing, unsecured, and payable on demand.
• Promissory note of $466,817 due to Tom Zapatinas as of February 28, 2025; this note is non-interest bearing, unsecured, and payable on demand.
• Convertible note payable of $1,058,760 due to Tom Zapatinas as of February 28, 2025; this note is non-interest bearing, unsecured, payable on demand, and convertible into 10,587,600 shares of common stock at $0.10 per share.
• Tom Zapatinas earned $0 for consulting services during the nine months ended February 28, 2025, compared to $60,000 in the prior year.

Stakeholder Impact

• Shareholders face significant risk of substantial dilution if the company proceeds with equity financing to raise capital.
• Shareholders also face a high risk of complete loss of investment due to the substantial doubt about the company's ability to continue as a going concern.
• Creditors, particularly arms-length creditors, face uncertainty regarding repayment, as the company explicitly states a need to raise capital to pay them.
• Employees (current and prospective) face job insecurity given the company's precarious financial position and the stated need to fill positions without guaranteed funding.

Next Steps

• Raise additional capital to execute business plans.
• Penetrate healthcare processing markets in Canada, the United States, and worldwide by continuing to develop innovative products and services.
• Build a network of strategic alliances with health insurance companies, governments, and other entities in various vertical markets.
• Fill senior management, sales, administrative, and engineering positions.

Key Dates

Recommendation

Keywords

Healthcare payment systems, Health spending accounts, HSA, Payment processing, Fintech, SEC filing, 10-Q, Going concern, Startup, Capital raise, Financial deficit, Related party transactions